Ohtuvayre 3 MG per 2.5 ML Inhalation Suspension
- RxCUI
- 2687226
- RxNorm name
- Ohtuvayre 3 MG per 2.5 ML Inhalation Suspension
- Display name
- Ohtuvayre 3 MG per 2.5 ML Inhalation Suspension
- Full name
- Ohtuvayre 3 MG per 2.5 ML Inhalation Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ohtuvayre | ENSIFENTRINE | MERCK SHARP & DOHME LLC | e6433c98-41a0-4f99-8f7f-d0e9db6e3f40 | 2026-04-23 | Warnings, Adverse reactions | 2687226 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e6433c98-41a0-4f99-8f7f-d0e9db6e3f40 | Ohtuvayre 3 MG in 2.5 ML Inhalation Suspension [PSN] · ensifentrine 1.2 MG/ML Inhalation Suspension [Ohtuvayre] [SBD] · Ohtuvayre 3 MG per 2.5 ML Inhalation Suspension [SY] | 3 | 6 | These highlights do not include all the information needed to use OHTUVAYRE™ safely and effectively. See full prescribing information for OHTUVAYRE. OHTUVAYRE (ensifentrine) inhalation suspension, for oral inhalation use Initial U.S. Approval: 2024 | 20260423 |